MorphoSys and GPC hit milestone in cancer deal

MorphoSys (NMarkt:MOR) said it delivered to partner GPC (Munich, Germany) a series of human antibodies that destroy specific cancer cells in lymphoma and leukemia. GPC will make a milestone payment to...